Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial ....

SHR EE G AN ESH BI O - T E C H (I ND I A) L I M I TED CIN: L70101WB1982PLC121196 Reg. Office: CUBICLE NO.: 126, 3/2, 75C, PARK STREET, 3RD FLOOR KAMDHENU BUILDING, KOLKATA -700016 Email: shreeganeshbiotechindialtd@gmail.com Website: www.shreeganeshbiotech.bar Date:03.09.2026 To, To, To, Listing Department, The Secretary, Head - Listing BSE Limited, The Calcutta Stock Metropolitan Stock Exchange of P J Tower, Dalal Street Exchange Ltd, India Limited Mumbai-400001 7, Lyons Range, Vibgyor Towers, 4th floor, Plot No C Kolkata - 700001 62, Opp. Trident Hotel Bandra Kurla Complex, Bandra (E), Mumbai – 400098 Scrip Code: 539470 Scrip Code: 29221 Scrip Code: SHREEGANES Dear Sir/Madam, Sub: Submission of Annual Report for the Financial Year 2025-26 Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2025-26 along with the Notice of 16th Annual General Meeting to be held on Monday 28th September, 2026. Thanking you. Yours faithfully For, SHREE GANESH BIO-TECH (INDIA) LIMITED Aman Patel Wholetime Director Encl.: As above. SHREE GANESH BIO-TECH (INDIA) LIMITED CORPORATE INFORMATION BOARD OF DIRECTORS: AMAN PATEL Wholetime Director KISHAN NITYANAND NAIDU Non-Executive Director SOMBIR SINGH Independent Director HARSHAD RATHOD Independent Director AMRUTABEN SOLANKI Independent Director NIMESHKUMAR PARMAR Independent Director HARSHADKUMAR RATHOD Independent Director KEY MANAGERIAL PERSONNEL: KISHAN NITYANAND NAIDU Chief Financial Officer NAMITA ACHARYA Company Secretary BOARD COMMITTEES: Audit:- SOMBIR SINGH Chairperson NIMESH PARMAR Member AMRUTABEN SOLANKI Member Nomination and Remuneration:- SOMBIR SINGH Chairperson NIMESH PARMAR Member AMRUTABEN SOLANKI Member Share Transfer and Grievances:- AMRUTABEN SOLANKI Chairperson NIMESH PARMAR Member SOMBIR SINGH Member Listing Details:- BSE Limited The Calcutta Stock Exchange Ltd MSE India Limited Statutory Auditors:- Secretarial Auditor:- M/s. Bipin & Co., M/S. Daksha Negi & Associates Chartered Accountants, Practicing Company Secretary Vadodara Ahmedabad BANKERS: Central Bank of India Bank of India Registered Office: Registrar & Transfer Agents: CUBICLE NO.:126,3/2 ,75C,PARK STREET,3RD FLOOR SATELLITE CORPORATE SERVICES PRIVATE LIMITED KAMDHENU BUILDING ,KOLKATA - 700016 Office No 106-107, Dattani Plaza, East West Compound, Phone: 033-23988213 Andheri Kurla Road, Safedpul Fax: 033-23968420 Sakinaka,Mumbai,Maharashtra,400072Phone: 022- E Mail: shreeganeshbiotechindialtd@gmail.com 28520461 Website: www.shreeganeshbiotech.bar E Mail: service@satellitecorporate.com Website: www.satellitecorporate.com Annual Report 2025-26 SHREE GANESH BIO-TECH (INDIA) LIMITED TABLE OF CONTENTS CORPORATE OVERVIEW STATUTORY REPORTS Notice of Annual General Meeting………………………………. Report on Corporate Governance……………………………….. FINANCIAL STATEMENTS Independent Auditor’s Report……………………………………... Notes to the Financial Statements…………………………………... Annual Report 2025-26 SHREE GANESH BIO-TECH (INDIA) LIMITED N O T I C E NOTICE is hereby given that the 16TH ANNUAL GENERAL MEETING of the Members of SHREE GANESH BIO- TECH (INDIA) LIMITED will be held at Registered office of the company CUBICLE NO.:126, 3/2, 75C, PARK STREET, 3RD FLOOR KAMDHENU BUILDING, KOLKATA - 700016 on Monday ,28th September, 2026 at 03:00 P.M. to transact the following business: ORDINARY BUSINESS: 1 To receive, consider and adopt the audited financial statements of the Company for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Independent Auditors thereon; 2 To appoint a Director in place of Mr. Aman Patel (DIN: 08483544), who retires by rotation being eligible, offers himself for re-appointment. By order of the Board, Registered Office: For SHREE GANESH BIO-TECH (INDIA) LIMITED CUBICLE NO.:126,3/2 ,75C,PARK STREET,3RD FLOOR KAMDHENU BUILDING, KOLKATA- 700016 Date: 14.05.2026 AMAN PATEL Chairman DIN: 08483544 Notes: 1. A member entitled to attend and vote, is entitled to appoint a proxy to attend and vote instead of himself/ herself and the proxy need not be a member of the company. Proxies in order to be effective must be deposited at the registered office of the company in not less than 48 hours before the time fixed for the meeting. The blank proxy form is enclosed. 2. In compliance with the MCA Circulars and SEBI Circular, Notice of the AGM inter-alia, indicating the process and manner of voting through electronic means along with the Annual Report 2024-25 is being sent only through electronic mode to those Members whose e-mail addresses are registered with the Company / Depositories. Members may note that the Notice and Annual Report 2024-25 will also be available on the Company’s website, websites of the Stock Exchanges i.e. BSE Limited and on the website of NSDL. 3. Corporate Members intending to send their authorised representative to attend the Annual General Meeting are requested to send to the Company a duly certified copy of the Board Resolution authorising their representative to attend and vote at the Annual General Meeting. 4. The Register of Members and Share Transfer Register of the Company will remain closed from 21st September, 2026 to 28th September, 2026 (both days inclusive). 5. Members are requested to send their queries to the Company, if any, on accounts and operations of the Company at least seven days before the meeting so that the same could be suitably answered at the meeting. 6. To facilitate easy and cheap transactions in its shares, the Company has dematerialised its shares. Majority of the shareholders have already availed of this facility and de-materialised their shareholdings. Shareholders who have not yet de-materialised their shareholdings are requested to avail of this facility and de-materialise their shareholdings at the earliest. As per Regulation 40 of SEBI Listing Regulations, as amended, securities of listed companies can be transferred only in dematerialized form with effect from 1st April, 2019, except in case of request received for transmission or transposition of securities. In view of this and to eliminate all risks associated with physical shares and for ease of portfolio management, members holding shares in physical form are requested to consider converting their holdings to dematerialized form. Members can contact the Company or RTA for assistance in this regard. 7. The Explanatory Statement pursuant to Section 102 of the Companies Act, 2013 is annexed hereto. 8. Route map for the venue of the Annual General Meeting is given separately along with attendance slip. Annual Report 2025-26 SHREE GANESH BIO-TECH (INDIA) LIMITED 9. The information or details required as per Regulation 36(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Secretarial Standard – 2 on General Meetings issued by the Institute of Company Secretaries of India, of the person seeking appointment/ re- appointment as a Director at the ensuing Annual General Meeting is as under: Name of the Director AMAN PATEL DIN 08483544 Date of Birth 29/03/1998 Nationality Indian Date of Appointment 21/03/2020 Expertise in specific functional Area and experience Operations and General Management Terms and Conditions of re-appointment along with details of Refer item no. 2 of the Notice remuneration sought to be paid Remuneration last drawn (including sitting fees, if any) Nil Directorship in other Companies (excluding Foreign, private and Section Refer Corporate Governance Report 8 companies) Membership of Committees in other Public Limited Companies Refer Corporate Governance Report No. of Shares held in the Company as on 31.03.2025 (Face Value ₹ 1/- Nil per share) Number of meetings of the Board attended during the Financial Year Refer Corporate Governance Report Relationship with other Directors, Manager and Key Managerial None Pers [Showing first 8,000 characters — download PDF for full document]